中药配方颗粒行业深度调整 多家上市公司去年业绩骤降

中国经营网
03 Apr

中药 配方颗粒是中药现代化的重要形式之一。自取消中药配方颗粒试点政策施行以及新旧国标切换3年来,中药配方颗粒行业发展仍处于深度调整中。近期,中药配方颗粒上市公司 中国中药 (0570.HK)、 红日药业 (300026.SZ)、 神威药业 (02877.HK)等陆续披露了2024年年报或预告,2024年中药配方颗粒业务收入较前一年度均有较大幅度下降,影响了公司整体业绩表现,其中行业龙头中国中药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10